QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Quantify Research welcome Audun Ohna to the team
2014-09-15
Quantify Research are delighted to welcome Audun Ohna to the team. Audun will be heading the newly established Oncology department. Welcome Audun!
Study co-authored by Anders Gustavsson estimates the cost of brain disorders in Spain at 84 billion Euro annually
A newly published study co-authored by Anders Gustavsson estimates the cost of brain disorders in Spain at 84 billion Euro annually. This corresponds to 8% of GDP and again shows that brain disorders presents a great societal challenge. Pubmed link
Quantify Research presents national and regional survey of osteoporosis care in Sweden
In the report “Swedish Osteoporosis Care”, Quantify Research presents a national and regional survey of osteoporosis care in Sweden. A full press release on the report is available here. Read the report in English here, or download the Swedish report from the Swedish Osteoporosis Association’s website.
Gustaf Ortsäter at European Hepatitis C Inventory workshop
Gustaf Ortsäter will attend the European Hepatitis C Inventory workshop – From theory to action, arranged by the European Liver Patient Association in Brussels on the 11th of June. Gustaf will present an economic model of the burden of Hepatitis C in Romania and take part in round table discussion about the ongoing policy initiatives concerning Hepatitis C.